• Pam3CSK4 as a TLR1/2 Agonist: Workflow, Innovation, and Tips

  2026-04-29

  Pam3CSK4 enables reproducible activation of innate immunity, allowing precise modeling of inflammatory and allergic responses. Here we detail stepwise protocols, advanced applications, and troubleshooting informed by recent neuro-immune breakthroughs to help researchers maximize experimental rigor and translational relevance.

• Chloroquine: Beyond Autophagy—A Systems Oncology Perspective

  2026-04-29

  Explore how Chloroquine (N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine) is redefining cancer research through multi-pathway modulation. This article offers a systems-level view, contrasting with existing resources, and provides detailed protocol guidance for advanced translational applications.

• Heptamethine Cyanine Dye Suppresses PGR in HR+ Breast Cancer

  2026-04-28

  This study introduces CA800-PR, a tumor-targeted heptamethine cyanine dye, as a novel strategy for hormone receptor-positive breast cancer. By selectively suppressing progesterone receptor activity and inducing Golgi fragmentation, CA800-PR demonstrates direct antitumor efficacy and immune activation potential, offering an alternative to standard endocrine therapies.

• Structure-Based Screening of Natural Inhibitors for SARS-CoV

  2026-04-28

  This study leverages structure-based virtual screening and molecular dynamics to identify natural product inhibitors of SARS-CoV-2 NSP15, highlighting thymopentin and oleuropein as highly stable and potentially therapeutic candidates. The findings provide a springboard for targeted antiviral research and illustrate methodological benchmarks for inhibitor discovery.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-04-27

  Mdivi-1 is a selective DRP1 inhibitor used to modulate mitochondrial fission in cellular and animal models. Its mechanism blocks Drp1-mediated mitochondrial division, reduces apoptosis, and supports neuroprotection in ischemic retina. Supported by both peer-reviewed evidence and benchmark protocols, Mdivi-1 from APExBIO is a reference compound in mitochondrial dynamics research.

• Mubritinib Enhances Cisplatin Efficacy via Mitochondrial Dis

  2026-04-27

  This study demonstrates that Mubritinib significantly augments the antitumor activity of cisplatin in non-small cell lung cancer (NSCLC) by targeting mitochondrial function, leading to increased ROS production and apoptosis. The findings refine our understanding of Mubritinib’s mechanisms in solid tumors and suggest its utility as a combination strategy for overcoming chemoresistance.

• ECL Western Blotting Substrate: Parameters, Workflow, and QC

  2026-04-26

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of horseradish peroxidase (HRP) activity in chemiluminescent Western blot assays. It is suitable for workflows in molecular biology, cancer biology, and signal transduction pathway research, but should not be used for fluorescent or radioisotopic detection. Its design enables multiple exposures and efficient blot re-probing, streamlining protein detection procedures.

• Spermine Tetrahydrochloride: Protocols & Troubleshooting in

  2026-04-25

  Spermine tetrahydrochloride from APExBIO stands out for its reproducible membrane stabilization and unique polyamine crosslinking, enabling robust workflows across protoplast protection, protein crystallization, and NMDA receptor signaling research. This guide distills key experimental strategies, actionable troubleshooting, and comparative evidence to empower next-generation life science assays.

• CCR5-Containing Extracellular Vesicles Drive RA Pathogenesis

  2026-04-24

  This study elucidates how CCR5-positive extracellular vesicles from synovial fibroblasts propagate inflammation and joint destruction in rheumatoid arthritis models. Blocking CCR5, including with Maraviroc, reverses these effects, highlighting a novel molecular target for RA intervention.

• Reliable mRNA Synthesis with HyperScribe™ All in One Kit (SK

  2026-04-24

  This article explores real-world lab scenarios where the HyperScribe™ All in One mRNA Synthesis Kit Plus 1 (ARCA, 5mCTP, ψUTP, T7, poly(A)), SKU K1064, addresses pain points in mRNA production for functional assays and RNA vaccine workflows. We provide evidence-backed answers to common experimental challenges, highlighting validated protocol parameters, quality control, and immune response mitigation enabled by this ARCA capped mRNA synthesis kit.

• Temporal Dynamics of Transcription Factor Activation by H2O2

  2026-04-23

  This study reveals that mammalian cells respond to hydrogen peroxide (H2O2) stress by activating distinct groups of transcription factors in a dose- and time-dependent manner. It identifies a key role for 2-Cys peroxiredoxins in orchestrating the temporal sequence of transcription factor activation, with implications for understanding oxidative stress, cell fate decisions, and disease pathogenesis.

• Elobixibat Hydrate: Applied Workflows for IBAT Inhibition

  2026-04-23

  Elobixibat hydrate enables precise and reproducible modulation of bile acid transport, unlocking translational workflows in chronic idiopathic constipation and metabolic dysfunction. Discover proven assay parameters, protocol enhancements, and troubleshooting strategies built around this highly selective ileal bile acid transporter inhibitor.

• Vemurafenib (PLX4032): Applied Workflows in Melanoma Researc

  2026-04-22

  Vemurafenib (PLX4032) empowers melanoma researchers to dissect MAPK pathway dynamics and resistance mechanisms with precision. This article translates advanced multi-omics insights and hands-on troubleshooting into actionable workflows, enabling robust proliferation inhibition and tumor regression studies.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Disc

  2026-04-22

  This study introduces a robust patient-derived gastric cancer assembloid model that integrates autologous tumor organoids with matched stromal cell subpopulations. The model enhances physiological relevance, uncovers drug resistance mechanisms, and provides a superior platform for personalized therapeutic screening and tumor microenvironment research.

• Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one): Precision

  2026-04-21

  Deferiprone enables reproducible, selective iron chelation for probing apoptosis, metabolic reprogramming, and cytoprotection in cellular and animal disease models. This guide translates state-of-the-art evidence into actionable workflows and troubleshooting strategies for advanced biomedical research.

408 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page